(1)
Evaluation the Serum Levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in Patients With Benign and Malignant Thyroid Tumors. Journal of Pharmaceutical Negative Results 2022, 13 (3), 559-571. https://doi.org/10.47750/pnr.2022.13.03.085.